Time between Symptom Onset and Assessment in Age-Related Macular Degeneration with Subfoveal Choroidal Neovascularization

作者: Rainer Schalnus , Carsten H. Meyer , Claudia Kuhli-Hattenbach , Marc Lüchtenberg

DOI: 10.1159/000239236

关键词:

摘要: Background: Therapy delay in neovascular age-related macular degeneration (NV-AMD) is associated with risk of visual deterioration. Methods: Retrospective cross s

参考文章(31)
C.H. Meyer, H.-M. Helb, N. Eter, Monitoring von AMD-Patienten unter Anti-VEGF-Therapie Ophthalmologe. ,vol. 105, pp. 125- 142 ,(2008) , 10.1007/S00347-008-1702-6
Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham, Matthew Feinsod, David R. Guyer, Pegaptanib for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 351, pp. 2805- 2816 ,(2004) , 10.1056/NEJMOA042760
James F. Vander, Craig M. Morgan, Howard Schatz, Growth Rate of Subretinal Neovascularization in Age-related Macular Degeneration Ophthalmology. ,vol. 96, pp. 1422- 1429 ,(1989) , 10.1016/S0161-6420(89)32740-0
Barbara L Brody, Anne-Catherine Roch-Levecq, Ronald G Thomas, Robert M Kaplan, Stuart I Brown, Self-management of Age-related Macular Degeneration at the 6-Month Follow-up: A Randomized Controlled Trial Archives of Ophthalmology. ,vol. 123, pp. 46- 53 ,(2005) , 10.1001/ARCHOPHT.123.1.46
Alejandro Oliver-Fernandez, Jeff Bakal, Shaun Segal, Gaurav K Shah, Ashish Dugar, Sanjay Sharma, None, Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie. ,vol. 40, pp. 313- 319 ,(2005) , 10.1016/S0008-4182(05)80074-2
Julia Bonastre, Claude Le Pen, Gis??le Soubrane, Gabriel Quentel, The burden of age-related macular degeneration: results of a cohort study in two French referral centres. PharmacoEconomics. ,vol. 21, pp. 181- 190 ,(2003) , 10.2165/00019053-200321030-00003